Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Harvard Bioscience (HBIO) Deferred Taxes (2016 - 2019)

Harvard Bioscience (HBIO) has disclosed Deferred Taxes for 10 consecutive years, with $42000.0 as the latest value for Q3 2019.

Quarterly Deferred Taxes fell 74.07% to $42000.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was -$2.9 million through Sep 2019, down 90.12% year-over-year, with the annual reading at -$2.9 million for FY2018, 80.62% down from the prior year.
Deferred Taxes for Q3 2019 was $42000.0 at Harvard Bioscience, up from -$1000.0 in the prior quarter.
The five-year high for Deferred Taxes was $16.1 million in Q4 2015, with the low at -$2.9 million in Q4 2018.
Average Deferred Taxes over 5 years is $745214.3, with a median of $1000.0 recorded in 2015.
The sharpest move saw Deferred Taxes tumbled 1019.05% in 2015, then surged 14933.33% in 2016.
Over 5 years, Deferred Taxes stood at $16.1 million in 2015, then crashed by 104.55% to -$734000.0 in 2016, then crashed by 115.8% to -$1.6 million in 2017, then crashed by 84.79% to -$2.9 million in 2018, then skyrocketed by 101.43% to $42000.0 in 2019.
According to Business Quant data, Deferred Taxes over the past three periods came in at $42000.0, -$1000.0, and -$2.9 million for Q3 2019, Q1 2019, and Q4 2018 respectively.